SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amaal Al Dakheel, Isabelle Beaulieu-Boire, Susan H Fox, Emerging drugs for levodopa-induced dyskinesia, Expert Opinion on Emerging Drugs, 2014, 19, 3, 415

    CrossRef

  2. 2
    F.I. Tarazi, Z.T. Sahli, M. Wolny, S.A. Mousa, Emerging therapies for Parkinson's disease: From bench to bedside, Pharmacology & Therapeutics, 2014, 144, 2, 123

    CrossRef

  3. 3
    Anne-Catherine Vijverman, Susan H Fox, New treatments for the motor symptoms of Parkinson’s disease, Expert Review of Clinical Pharmacology, 2014, 7, 6, 761

    CrossRef

  4. 4
    Eva Schaeffer, Andrea Pilotto, Daniela Berg, Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease, CNS Drugs, 2014, 28, 12, 1155

    CrossRef

  5. 5
    Rukmini Mridula Kandadai, Shaik Afshan Jabeen, Meena A Kanikannan, Rupam Borgohain, Safinamide for the treatment of Parkinson’s disease, Expert Review of Clinical Pharmacology, 2014, 7, 6, 747

    CrossRef

  6. 6
    Rupam Borgohain, Jozsef Szasz, Paolo Stanzione, Chandrashekhar Meshram, Mohit H. Bhatt, Dana Chirilineau, Fabrizio Stocchi, Valentina Lucini, Rodolfo Giuliani, Emma Forrest, Patricia Rice, Ravi Anand, Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease, Movement Disorders, 2014, 29, 10